Gilead Sciences Inc buy stefan
Start price
29.04.20
/
50%
€77.15
Target price
20.09.20
-
Performance (%)
-28.79%
End price
20.09.20
€54.94
Summary
This prediction ended on 20.09.20 with a price of €54.94. The prediction for Gilead Sciences Inc disappointed with a performance of -28.79%. Dividends of €1.17 are taken into consideration when calculating the performance. stefan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Gilead Sciences Inc | 5.575% | 5.575% | -2.700% | 15.288% |
iShares Core DAX® | -0.130% | 1.601% | 13.900% | 16.793% |
iShares Nasdaq 100 | -5.156% | -2.343% | 30.120% | 47.391% |
iShares Nikkei 225® | -3.402% | 2.990% | 12.946% | 9.565% |
iShares S&P 500 | -1.733% | 0.290% | 28.669% | 44.958% |
Comments by stefan for this prediction
In the thread Gilead Sciences Inc diskutieren
Gibt wohl doch positive Nachrichten zum Corona Medikament
https://www.cnbc.com/2020/04/28/stock-market-futures-open-to-close-news.html?__source=iosappshare%7Ccom.apple.UIKit.activity.CopyToPasteboard
https://www.cnbc.com/2020/04/29/gilead-reports-positive-data-on-remdesivir-coronavirus-drug-trial.html?__source=iosappshare%7Ccom.apple.UIKit.activity.CopyToPasteboard
https://www.cnbc.com/2020/04/28/stock-market-futures-open-to-close-news.html?__source=iosappshare%7Ccom.apple.UIKit.activity.CopyToPasteboard
https://www.cnbc.com/2020/04/29/gilead-reports-positive-data-on-remdesivir-coronavirus-drug-trial.html?__source=iosappshare%7Ccom.apple.UIKit.activity.CopyToPasteboard
In the thread Trading Gilead Sciences Inc
Buy beendet